Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05961592 · ClinicalTrials.gov registry record · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
A Phase 1 study of Arthritis, Rheumatoid, sponsored by Rise Therapeutics.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 73
- Enrollment target
- 5
- Study locations
NCT05961592 is a Phase 1 study of Arthritis, Rheumatoid that is actively recruiting participants, run by Rise Therapeutics. The registered enrollment target is 73 participants, below the 638-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (89% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT05961592, a Phase 1 study of Arthritis, Rheumatoid, is actively recruiting participants, sponsored by Rise Therapeutics.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 73 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-2487) in patients with Rheumatoid Arthritis. Patients will take an oral dosage of probiotic (R-2487) and physicians will assess and measure their Rheumatoid Arthritis. Blood and fecal evaluations of inflammation and assessment of probiotic (R-2487) on fecal level will also be measured.
Conditions Studied
Interventions
- DRUG R-2487 DP
Study Locations (5)
Florida
- St.Jude Clinical Research - Doral
- AP Medical Research - Miami
California
- University of California, San Diego - San Diego
Pennsylvania
- Altoona Center for Research - Duncansville
Texas
- Prolato Clinical Research Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2023-10-19 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05961592
The ClinicalTrials.gov registry entry for NCT05961592 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 638-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (89% lower). The listed sponsor is Rise Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Arthritis, Rheumatoid appearing as the primary indexed condition, and to 1 intervention - of which R-2487 DP is the first listed.
NCT05961592 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Florida, California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05961592 about?
NCT05961592 is a clinical study titled "R-2487 in Patients With Rheumatoid Arthritis". The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-2487) in patients with Rheumatoid Arthritis. Patients will take an oral dosage of probiotic (R-2487) and physicians will assess and measure their Rheumatoid Arthritis. Blood and fecal evaluations of infl...
What is the current status of trial NCT05961592?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 73 participants. The study started on 2023-10-19. Estimated completion is 2026-12-31.
What conditions does trial NCT05961592 study?
This clinical trial studies the following conditions: Arthritis, Rheumatoid.
What interventions are being tested in trial NCT05961592?
The interventions under investigation include: R-2487 DP (DRUG).
Who is sponsoring clinical trial NCT05961592?
This trial is sponsored by Rise Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05961592 being conducted?
This trial has 5 study locations across California, Florida, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthritis, Rheumatoid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection
COMPLETED · Phase 1
-
Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis
COMPLETED · Phase 1
-
A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis
COMPLETED · Phase 1
-
Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA
COMPLETED · Phase 1
-
Chronic Pain in Rheumatoid Arthritis
RECRUITING
-
IMPACT - AndHealth Autoimmune Research Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.